Subscribe
covid_siam-pukkato
siam.pukkato / Shutterstock.com
25 May 2021Big PharmaAlex Baldwin

Under-pressure pharma groups release vaccine scale-up plan

Several pharmaceutical organisations have joint-published a five-step plan to help provide more equitable access to COVID-19 vaccines that would avoid waiving IP rights.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
CPI receives £5m from UK govt for 'vaccine library'
4 March 2021   UK innovation hub CPI has received a further £5 million investment from the UK government to support the development of new mRNA vaccines to protect against new variants of COVID-19.
Big Pharma
Pressure on Ireland to back COVID vaccine IP waiver
12 March 2021   Ireland is the latest country to come under pressure to back the World Trade Organisation’s appeal to waive intellectual property rights related to COVID-19 vaccines, as developing countries struggle to vaccinate their populace.
Big Pharma
Is big pharma’s antidote to the COVID-19 waiver a viable alternative?
29 July 2021   In May, a consortium of pharmaceutical companies came together to pitch a new plan to help provide more equitable access to COVID-19 vaccines.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Big Pharma
CPI receives £5m from UK govt for 'vaccine library'
4 March 2021   UK innovation hub CPI has received a further £5 million investment from the UK government to support the development of new mRNA vaccines to protect against new variants of COVID-19.
Big Pharma
Pressure on Ireland to back COVID vaccine IP waiver
12 March 2021   Ireland is the latest country to come under pressure to back the World Trade Organisation’s appeal to waive intellectual property rights related to COVID-19 vaccines, as developing countries struggle to vaccinate their populace.
Big Pharma
Is big pharma’s antidote to the COVID-19 waiver a viable alternative?
29 July 2021   In May, a consortium of pharmaceutical companies came together to pitch a new plan to help provide more equitable access to COVID-19 vaccines.

More on this story

Big Pharma
CPI receives £5m from UK govt for 'vaccine library'
4 March 2021   UK innovation hub CPI has received a further £5 million investment from the UK government to support the development of new mRNA vaccines to protect against new variants of COVID-19.
Big Pharma
Pressure on Ireland to back COVID vaccine IP waiver
12 March 2021   Ireland is the latest country to come under pressure to back the World Trade Organisation’s appeal to waive intellectual property rights related to COVID-19 vaccines, as developing countries struggle to vaccinate their populace.
Big Pharma
Is big pharma’s antidote to the COVID-19 waiver a viable alternative?
29 July 2021   In May, a consortium of pharmaceutical companies came together to pitch a new plan to help provide more equitable access to COVID-19 vaccines.

More features

Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?
Pfizer infringed haemophilia therapy patent, says court
Cooley adds ex-Gowling partner